أفضل بودكاسات John LePore (2024)

1
Expanding The Proteome with ProFound's John Lepore, M.D. 56:38

4d ago56:38

56:38

We love to hear from our listeners. Send us a message. Flagship Pioneering’s ProFound Therapeutics is on to something, and it could be something big. It began with a simple question: What if more RNAs were being translated into proteins? Answering that question took ProFound deep into the translatome, where it’s now studying the full compendium of …

1
Unlock the Secrets of Motion Design with Jonathan Winbush 1:09:12

8d ago1:09:12

1:09:12

Join E.J. Hassenfratz and Jonathan Winbush on the School of Motion Podcast as they explore diverse toolsets, Unreal Engine, and the evolving motion design industry. URL: https://www.schoolofmotion.com/blog/jonathan-winbushبقلم The School of Motion Podcast

1
From The Bench To The Boardroom with ImmunityBio's Enrique Diloné 1:06:39

11d ago1:06:39

1:06:39

We love to hear from our listeners. Send us a message. While organic chemistry lectures caused many of his peers at NYU to wring their hands, gnash their teeth, and question life choices, then-19-year-old Enrique Diloné ate those classes for lunch. They inspired him to earn a Seton Hall Ph.D. in chemistry, and to go to work as a big bio research sc…

1
First AI Antibody In Humans with Aulos' Aron Knickerbocker 1:08:52

18d ago1:08:52

1:08:52

We love to hear from our listeners. Send us a message. Data drives decision-making at Aulos Bioscience. It's also driven the career trajectory of its CEO. On this week's episode of the Business of Biotech podcast, we get an introspective walk through Aron Kinickerbocker's strategically-orchestrated career path, from his early days in the labs at Br…

1
From Red Giant to Unreal Engine: Aharon Rabinowitz on the State of Mograph 1:32:03

22d ago1:32:03

1:32:03

In this week's School of Motion Podcast, Joey sits down with our very own Aharon Rabinowitz, who looks back on his journey into the world of motion graphics and animation — and the potential future ahead. Check out the corresponding blog post here: https://www.schoolofmotion.com/blog/aharon-rabinowitz…

1
Drug Delivery Differentiators with Syncromune's Eamonn Hobbs 1:12:31

25d ago1:12:31

1:12:31

We love to hear from our listeners. Send us a message. Syncromune's Sync-T solid tumor therapeutic platform is, in a word, complex. The company's three phase 1 programs combine T-cell science with a proprietary drug delivery device to target solid tumors, specifically metastatic breast, non-small-cell lung, and castrate-resistant prostate cancers. …

1
Topical Ocular Biologics with Claris Bio's Clarke Atwell 58:06

1M ago58:06

58:06

We love to hear from our listeners. Send us a message. Built on the back of hepatocyte growth factor discoveries by Harvard Drs. Reza Dana and Sunil Chauhan, ClarisBio is rewriting the ophthalmology rulebook. CEO Clark Atwell acknowledges that it's not the first to bring topically-administered biologic therapies to the front of the eye, but if succ…

1
Beeple on NFTs, AI, and the Future of Digital Art 1:09:52

1M ago1:09:52

1:09:52

We were stoked to have design trailblazer and animator Beeple join us on the SOM podcast. He shares insights on the NFT boom, how AI augments artistic work, and offers valuable advice for up-and-coming designers. Check out the corresponding blog post here: https://www.schoolofmotion.com/blog/beeple-nfts-ai…

1
C&G Regulatory Guidance with Lineage Therapeutics' Brian Culley 1:04:02

1M ago1:04:02

1:04:02

We love to hear from our listeners. Send us a message. When we last caught up with Brian Culley, CEO at Lineage Cell Therapeutics, it was January, 2021. A pandemic was raging. His company was moving mountains to keep its OpRegen dry AMD clinical trial together, and did so despite lockdowns that kept a largely aged patient population from setting fo…

1
True DEI Value in Biopharma with Arcellx's Rami Elghandour 1:04:08

2M ago1:04:08

1:04:08

We love to hear from our listeners. Send us a message. The cell therapy company Arcellx has, by any and every measure, been outperforming its peers. Its stock has rallied on the back of the strong performance of its multiple myeloma candidate, and the promise of its AML, MDS, and solid tumor pipelines is attracting the kind of interest it takes to …

1
Designing the Super Bowl in Unreal Engine: In the Trenches with Marcos Vaz 1:11:52

2M ago1:11:52

1:11:52

Discover how designer and art director Marcos Vaz masters client collaboration and creative problem-solving. Check out the corresponding blog post: https://www.schoolofmotion.com/blog/marcos-vazبقلم The School of Motion Podcast

1
Mission-Driven Dementia Funding with DDF's Jonathan Behr 55:46

2M ago55:46

55:46

We love to hear from our listeners. Send us a message. If there's anyone qualified to analyze an early-stage therapeutic technology and place bets with other people's money, it's scientist-turned-venture capitalist Jonathan Behr, Ph.D. He built a distinguished venture capital career on the back of an MIT Ph.D. in biological engineering, having co-f…

1
ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller 1:04:06

2M ago1:04:06

1:04:06

We love to hear from our listeners. Send us a message. Just a few years ago, Daiichi Sankyo wasn't considered a player in the oncology therapeutics space, and it certainly wasn't a player in ADCs. But then, just a few years ago, who was? Fast forward to 2023, and we see an ADC arena that drove nearly $100 billion in M&A, licensing, and partnership …

1
Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D. 56:38

2M ago56:38

56:38

We love to hear from our listeners. Send us a message. Mythic Therapeutics Chief Scientific Officer and co-founder Brian Fiske, Ph.D. broke some unwritten protocol with his rapid and multifaceted transition from academia to industry. He calls his many, and sometimes concurrent, early experiences as an MIT Ph.D. student, a Flagship Ventures Fellow, …

1
Designing the Future: A Deep Dive with John LePore on Motion and Design Trends 1:27:59

2M ago1:27:59

1:27:59

Creative legend John LePore joins us on the podcast! Join us as we dive deep into current and future trends in motion and design. If you're not familiar with the name John LePore, you're almost certainly familiar with his work. John has made creative contributions to Marvel Studios' Black Panther, the Hummer EV, and Pixar’s Lightyear. He has worked…

1
The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch 57:35

2M ago57:35

57:35

We love to hear from our listeners. Send us a message. This isn't your typical drug sponsor + CDMO story. In fact, CTMC's Jason Bock, Ph.D. says you shouldn't even classify his company a CDMO. He's not wrong. While some of the company's services aren't dissimilar from those offered by a contract developer, CTMC began with a more fundamental mission…

1
Oscar Mar on Blending Business, Design, and Creative Exploration 1:05:44

3M ago1:05:44

1:05:44

Oscar Mar joins us on the School of Motion Podcast, where he shares his journey from designer to founder, blending business savvy with creative exploration in sci-fi entertainment. See the full blog post here: https://www.schoolofmotion.com/blog/oscar-mar-parallelبقلم The School of Motion Podcast

1
A New Prescription For PBMs with Allan Shaw 40:13

3M ago40:13

40:13

We love to hear from our listeners. Send us a message. Back by popular demand, biopharma industry opinionator extraordinaire Allan Shaw rejoins the Business of Biotech to expose the murky role Pharmacy Benefit Managers (PBMs) play in the last, costly mile of the drug distribution supply chain. Allan pulls no punches in his criticism of the current …

1
New Apps For AI in mRNA With Anima Biotech's Yochi Slonim 59:10

3M ago59:10

59:10

We love to hear from our listeners. Send us a message. From San Francisco’s Silicon Valley to Tel Aviv’s Silicon Wadi, software business entrepreneur Yochi Slonim made a name for himself in global tech hubs around the globe. Notably, he was co-founder of billion-dollar Mercury Interactive, which HP acquired for $4.5 billion, and previous to that a …

1
Design That Sells: Unpacking the Magic of Web + Motion with Ran Segall 1:08:23

3M ago1:08:23

1:08:23

Dive into web design with full-stack designer turned founder Ran Segall, as he dishes out on blending aesthetics, functionality, and business strategy to skyrocket your design approach. Check out the corresponding blog post here: https://www.schoolofmotion.com/blog/design-web-motion-ran-segallبقلم The School of Motion Podcast

1
Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch 59:11

3M ago59:11

59:11

We love to hear from our listeners. Send us a message. As if Orna Therapeutics' CEO Thomas Barnes, CEO isn't a enough to draw you in to the Business of Biotech, we teamed up with Advancing RNA Editorial & Community Director Anna Rose Welch to co-host this week's episode. Together, Anna Rose and I press Dr. Barnes on his transition from academia to …

1
Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D. 1:01:30

3M ago1:01:30

1:01:30

We love to hear from our listeners. Send us a message. Novel technologies aren’t interesting to Rahul Kakkar, M.D. unless they help patients. Sounds rational, but it’s actually a unique perspective in a platform-crazed biotech industry. Dr. Kakkar’s worldview is shaped by his work as a physician—work he continues at Brigham and Women’s Hospital eve…

1
Collin Leix from Gunner on the Intersection of Artistry and VR Innovation 1:17:58

4M ago1:17:58

1:17:58

Check out the corresponding blog post and key takeaways here: https://www.schoolofmotion.com/blog/c... Dive into the latest episode of the School of Motion Podcast as we hang out with Collin Leix, the brilliant mind blending traditional artistry with the limitless possibilities of VR. Collin is a full time animator at Gunner, now part of the innova…

1
Commercial Readiness with ImmunityBio's Bobby Reddy, M.D. 56:54

4M ago56:54

56:54

We love to hear from our listeners. Send us a message. This episode of the Business of Biotech begins with a personal story about my dad and the standard of care in bladder cancer, before shifting to the work that Dr. Bobby Reddy and his team at ImmunityBio are doing to change that standard of care. They're painfully close. Dr. Reddy, Chief Medical…

1
Chris Do on Creative Work: The Design Economy, Remote Work, and Evolving Skill Sets 1:05:57

4M ago1:05:57

1:05:57

We dive deep with Emmy award-winning designer and the Futur founder, Chris Do, as he unveils game-changing insights for creative professionals. Get the show notes: https://www.schoolofmotion.com/blog/chris-do

1
Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, D.Phil. 49:47

4M ago49:47

49:47

We love to hear from our listeners. Send us a message. Ampersand Biomedicines CEO Jason Gardner, D.Phil. first took the leap from a global pharmaceutical giant to a startup at the forefront of transplant medicine innovation. Since that time, he's seen most of the ups and the downs that come with biotech leadership, and in his latest venture with th…

1
Funding Alzheimer's Tx Dev with ADDF's Karen Harris 40:16

4M ago40:16

40:16

We love to hear from our listeners. Send us a message. We've really been looking forward to dropping this episode with Karen Harris, Chief Financial Officer and Head of Mission-Related Investing at the Alzheimer's Drug Discovery Foundation. While the markets have warmed a bit since we recorded this episode, Karen's thoughtful perspective on the som…

1
The AI Impact with Generate:Biomedicines' Mike Nally 1:13:54

4M ago1:13:54

1:13:54

We love to hear from our listeners. Send us a message. Few drug discovery and development concepts are as hyped, and as such, draw as much polarity from drug developers, as machine learning and artifical intelligence. One company on the bullish end of the spectrum is Flagship Pioneering's Generate Biomedicines, which bills itself at the "intersecti…

1
Karin Fong on Art Direction, Mentorship, and Legendary Title Design 1:26:00

4M ago1:26:00

1:26:00

We go 1:1 with the one and only Karin Fong—Emmy award-winning director, designer, and founder of the creative agency Imaginary Forces. Check out the corresponding blog post here: https://www.schoolofmotion.com/blog/karin-fongبقلم The School of Motion Podcast

1
Strategic Deals with CinRx's Gavin Samuels, M.D. 47:52

5M ago47:52

47:52

We love to hear from our listeners. Send us a message. Gavin Samuels, M.D. found his work as an intensive care physician boring. After earning his M.D., he did that for a few years before moving into intensive care management roles. It wasn't until he left the hospital and entered biopharma that he found his footing, cutting his teeth in business d…

1
Serial Success With Triumvira's Rob Williamson 31:32

5M ago31:32

31:32

We love to hear from our listeners. Send us a message. Rob Williamson's mind and hands have shaped more than 20 biotech startups, leading some to IPO and landing others firmly in Big Bio through acquisition by companies like Merck. Hanging around as many successful exits as Williamson has seen, one might become expert via osmosis. But Williamson is…

1
Textures, Photoshop, and the Creative Journey with Brady Erickson 1:16:52

5M ago1:16:52

1:16:52

From playing guitar in the underground music scene with his band Slowburn, Brady's journey shifted gears to tweaking pixels in LA and founding Texturelabs, an online tutorial and assets site. His transition from the world of music to the realm of visual arts is a testament to the fluidity of creative expression. Brady shares actionable tips and ins…

1
The Innovator's Dilemma with Lumen Bioscience's Brian Finrow, J.D. 50:43

5M ago50:43

50:43

We love to hear from our listeners. Send us a message. In biotech, when "one of these things doesn't look like the other one," it can be a blessing or a curse. On one hand, scientific novelty is praised and rewarded. On the other, unfamiliarity breeds skepticism from the investment community. Brian Finrow, J.D. embraces that reality and the challen…

1
Precision Radiopharmaceuticals with Ratio's Jack Hoppin, Ph.D. 40:38

5M ago40:38

40:38

We love to hear from our listeners. Send us a message. Multimodal approaches to the delivery of radiologically active compounds have created a fertile environment to for players in the space to put on a precision medicine clinic, so to speak. What’s more, Radiopharmaceuticals create a unique business opportunity given the closely-related and necess…

1
Character Design and Artistic Growth: Insights from Emma Gillette 59:42

5M ago59:42

59:42

In our latest podcast episode, Emma Gillette, a professional illustrator and instructor of the newly released Character Design Fundamentals course, shares her experiences and insights, providing actionable lessons for fellow artists and designers. Check out the corresponding blog post: https://www.schoolofmotion.com/blog/emma-gillette Show Notes Em…

1
Managing Mergers With Sail Biomedicines' Guillaume Pfefer, Ph.D. 51:07

5M ago51:07

51:07

We love to hear from our listeners. Send us a message. While you might be aware that Sail Biomedicines was just formed up in Q4 of last year, the product of Flagship Pioneering’s decision to merge Senda Biosciences and Laronde, two of its programmable medicine platform companies. What you likely haven’t heard is the inside story on how the merger w…

1
Reprogramming Human Cells With bit.bio's Mark Kotter, M.D. 45:51

6M ago45:51

45:51

We love to hear from our listeners. Send us a message. The concept of programmable biology is fueling a new breed of biotech, one that requires the marriage of computational and traditional science (and both computational and traditional scientists) on the entire journey from discovery to commercial. Bit.bio is exemplary of this new breed. Its CEO,…

1
NFT Success and The Future of Motion with Rive CD Jerry Liu 1:08:30

6M ago1:08:30

1:08:30

In this week’s podcast we’re talking to Jerry Liu - Creative Director at Rive, and a man who has seen a lot in his motion design career. He’s done plenty of studio work, did a stint at Meta, made 7-figures selling NFTs, and now he’s deep in the fast-growing world of interactive motion design. In this conversation, Jerry talks transparently about hi…

1
Inhalable mRNA with Ethris' Carsten Rudolph, Ph.D. 46:59

6M ago46:59

46:59

We love to hear from our listeners. Send us a message. Without doubt, the grand and collaborative experiment that was the mRNA COVID vaccine contributed mightily to the pandemic response and continues to save lives untold. It also demonstrated the collective power of public/private partnership in biopharma. Having acknowledged that, no first iterat…

1
Biotech Is Back with Allan Shaw 51:02

6M ago51:02

51:02

We love to hear from our listeners. Send us a message. The Business of Biotech took a trip to San Francisco for the JP Morgan Healthcare Conference, that most target-richest of environments for those of us who like talking shop with biotech builders. The results of that trip will feed the next several weeks of Business of Biotech podcast programmin…

1
How to Win in 2024 | Thoughts and Tips for Motion Designers 54:07

6M ago54:07

54:07

We slice through the noise and focus on the real factors that will drive motion design success this year. And heads-up: It's more than just the latest tools and trends. :) Check out the corresponding blog post: https://www.schoolofmotion.com/blog/a... SCHOOL OF MOTION COURSES All Courses - https://som.bz/3SUg5Yb After Effects Kickstart - https://so…

1
Multimodal R&D Management with Incyte's Jim Lee, M.D., Ph.D. 50:31

6M ago50:31

50:31

We love to hear from our listeners. Send us a message. Success at multimodal, multi-indication, deep-pipelined Incyte—where commercial operations are as familiar as pre-discovery activity is—begins at the earliest opportunity to achieve research and discovery efficiencies. The company’s a bit larger than those we typically cover on the Business of …

1
Building A Biotech Hub with Intellia Therapeutics' John Leonard, M.D. 55:03

7M ago55:03

55:03

We love to hear from our listeners. Send us a message. We spend a lot of time talking with our guests about building biotech companies. That’s true of this episode too, but today we’re taking a step further with John Leonard, M.D., longtime CEO at Intellia Therapeutics. In addition to how he’s built late-clinical stage Intellia, Dr. Leonard shares …

1
The Past and Future of Motion: Simon Robson on AI, Evolution and Staying Curious 1:37:57

7M ago1:37:57

1:37:57

Join us as we dive into the world of motion design with Simon Robson, exploring the evolution from early 2000s experimental scenes to today's AI-driven creative production. Get more info and explore Simon's work: https://www.schoolofmotion.com/blog/simon-robson Show Notes Joshua Davis (Praystation) OneDotZero Jamie Hewlett Lightwave Cinema 4D Imagi…

1
Art Of The Pivot with Elevation Oncology's Joe Ferra 49:56

7M ago49:56

49:56

We love to hear from our listeners. Send us a message. Relatively new CEO Joseph Ferra has orchestrated some pretty significant change at Elevation Oncology in the two(ish) years since the Business of Biotech last hosted the company. In that short time, Ferra advance from CFO to CEO, a move that aligned very closely with the company's difficult dec…

1
CDMO Collab with Scorpius BioManufacturing's Steve Lavezoli + Fina Biosolutions' Dr. Andrew Lees 51:41

7M ago51:41

51:41

We love to hear from our listeners. Send us a message. A new year marks a fresh start for biotech partnerships, and to kick off 2024, we're highlighting a good one. Fina Biosolutions' Dr. Andrew Lees recently signed on with Scorpius BioManufacturing to support his company's growth plan. On today's episode of the Business of Biotech, Lees sits down …

1
2023: The Year In Mograph 6:48:46

7M ago6:48:46

6:48:46

Get ready for the School of Motion's annual end-of-the-year podcast extravaganza, featuring an epic and (record-breaking!) discussion. Show Notes People EJ Hassenfratz Ryan Summers Austin Bauwens Amanda Russell Sekani Solomon Marina Nakagawa Jonathan Winbush Nick Forshee Justin Cone Joe Nash Chad Ashley Hayley Akins Kelsey (Premiere Gal) Barton Dam…

1
Biotech Down Under with BiomeBank's Dr. Sam Costello 1:06:13

7M ago1:06:13

1:06:13

We love to hear from our listeners. Send us a message. Merry Christmas, Business of Biotechers! On this Christmas Day release, we’re taking a trip to the land down under to visit with Dr. Sam Costello, a former gastroenterologist-turned managing director and co-founder at Adelaide, Australia-based BiomeBank. We covered some ground on this one, most…

1
IL-2 Program Profits with Bonum's Drs. John Mulligan and Neela Patel 1:08:42

8M ago1:08:42

1:08:42

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we welcome two extraordinary guests - Dr. Neela Patel, a molecular biologist-turned-Chief Business Officer, and Dr. John Mulligan, an academic-turned-founder of newly-formed Bonum Therapeutics. Together, Neela and John will pull back the curtai…

1
Rive and the future of interactive design 1:33:45

8M ago1:33:45

1:33:45

Let's get real about Rive. Guido Rosso, Rive’s CEO, pitches Rive as the next step in vector graphics and interactive design, a tool easy to pick up for After Effects veterans and powerful enough to dominate interaction design. Get the full scoop here: https://www.schoolofmotion.com/blog/rive Show Notes Rive Guido Rosso Kurt Hartfelder Jerry Liu Her…

المدونة الصوتية تستحق الاستماع

John LePore بودكاست

المدونة الصوتية تستحق الاستماع

دليل مرجعي سريع